EHAVE, Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Benjamin Kaplan
- Full Time Employees
- 1
- Sector
- Technology
- Industry
- Software - Application
- Address
- 100 South East 2nd Street Miami FL United States of America 33131
- IPO Date
- Dec 15, 2016
- CIK
- 0001653606
- Website
- ehave.com
- Similar Companies
- Business
- Ehave Inc develops and markets advanced healthcare software solutions focused on mental health data and medical psychedelics. The company offers a mental health data platform integrating proprietary and third-party digital assessment and therapeutic applications. Key products include MegaTeam and Ninja Reflex, clinically validated digital cognitive assessment and rehabilitation software embedded in engaging video game environments; Ehave Dashboard, a mental health informatics platform utilizing blockchain technology for objective clinical decision-making; and AI HeadHunter, an AI-powered recruitment engine designed for headhunters. Ehave also provides platforms enabling medical practitioners to deliver healthcare services remotely, targeting clinicians, patients, researchers, pharmaceutical companies, and payors primarily in Canada and the United States. Founded in 2011 and headquartered in Miami, Florida, Ehave operates at the intersection of healthcare and technology, emphasizing data-driven mental healthcare solutions. In recent developments, Ehave acquired AIHeadHunter, expanding into AI-powered recruitment within the healthcare sector, through a $10 million deal including a $2.7 million Series A convertible preferred funding component. The acquisition enhances its portfolio beyond healthcare software to include AI-driven talent acquisition technologies. The company also signed a letter of intent for an acquisition of DigiTrax Entertainment, a music AI technology firm, for $40 million, aiming to integrate advanced AI capabilities further into its offerings. These moves represent strategic expansion into AI and digital innovation sectors, aligning with Ehave’s objective to leverage artificial intelligence and data analytics to optimize mental health care and related digital services. The company’s operations focus extensively on mental health, ADHD care optimization, and medical cannabis treatment validation, supported by ongoing partnerships and licensing agreements to expand clinical applications and patient engagement technologies. Ehave’s core industry segments include digital healthcare technology, medical psychedelics development, mental health informatics, and AI-powered recruitment services. Its products serve a broad customer base including healthcare providers, clinical researchers, mental health professionals, pharmaceutical entities, and payors. The company's platforms facilitate objective, data-driven mental health patient management and treatment optimization, targeting markets in North America with ongoing technological and clinical advancements. Ehave's integration of blockchain technology and AI exemplifies its commitment to secure, innovative healthcare solutions that enhance clinical decision-making and operational efficiency. Ehave Inc's headquarters is in Miami, Florida, and it was incorporated in 2011. Its leadership continues to drive growth through strategic acquisitions, product development, and collaborations that enhance its digital mental health and AI technology ecosystem. With its flagship software products and recent acquisitions, Ehave positions itself as a forward-looking player in mental health and healthcare technology markets, emphasizing cutting-edge digital platforms and artificial intelligence-driven solutions.
AIBotics Enters Strategic AI Partnership and Joint Venture with ARYA AI Labs to Advance Next-Generation Deterministic “World Models”
Israeli Cannibble Food-Tech and AIBotics Enter Israel with Global Partner KEENON Robotics
AIBotics Ushers in a New Era as Intelligent Service Robotics Arrive in Tel Aviv, Redefining Human-Machine Interaction
AIBotics Signs LOI to Acquire Google Partner NovaCore Labs and Partners with KEENON Robotics to bring XMAN and Service Robots to Jamaica and the CARICOM
KEENON Robotics, Creator of XMAN and One of the World's Global Leaders and Largest Robotic Manufacturers, Signs Partnership Agreement With Aibotics
AIBotics Launches First Pilot Program with One of Miami's Elite Fitness Centers to Introduce Phill Robot™ in High-End Recovery Lounges
Mycotopia Therapies Inc. Announces Name Change to AIBiotics, Inc. and Symbol Change to AIBT
Making Ehave Great Again
Ehave Hires Contract Research Organization To Conduct Ketamine Clinical Trial In Miami, Florida
Psychedelic Stock Review Initiates Coverage on Ehave Inc.
Ehave Announces Inclusion in the 2021 Psychedelic Investor Guide
Ehave Appoints Board-Certified Gastroenterologist And Licensed Physician Dr. Rahul Dixit To Its Medical Advisory Board
Ehave Announces Update On Ehave Medical App With The Launch Of Covid Vaccine Passport Going Live Shortly
Ehave Files 6-K Disclosing LOI Details For The Acquisition Of Moksha Digital Software
Ehave Accelerates Growth With LOI To Acquire India Based Moksha Digital, A Medical Imaging Software Provider
Ehave Files 6-K Disclosing Research Project Agreement
Ehave Releases Additional Information On Partnership With Cutting Edge Data Provider As It Expands Capabilities
Ehave Hires Institutional Review Board (IRB) As It Solidifies Partnership With Tristar Wellness Launching Ketamine Clinical Trials In Miami
Ehave, Inc. To Be One Of Four Main Sponsors At The Third Annual Psytech Summit on July 19th and 20th, 2021
Health Wizz Co-Founder, Dr. Nitin Desai, To Assist And Advise Ehave On Mental Health Analytical Platforms